Susanne S.
- Country
- Germany
- Department
- Medizinische Klinik für Hämatologie und Internistische Onkologie
Research Overview
- Evaluation of PXS-5505 Combined with 5-Azacitidine in Patients with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
- Evaluation of Venetoclax and Azacitidine Combination Therapy Versus Placebo and Azacitidine in Treatment-Naïve Patients with Higher-Risk Myelodysplastic Syndrome
- Efficacy of Luspatercept in Erythropoiesis-Stimulating Agent-Naive Lower-Risk Myelodysplastic Syndromes with Anemia and Transfusion Independence
Data & Insights
Has run more than one trial at 6 of 80 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating myelodysplastic neoplasms (MDS) and chronic myelomonocytic leukemia (CMML), with particular focus on higher-risk disease variants.
- Myelodysplastic Syndrome Management
- CMML Treatment Approaches
- Higher-Risk MDS Therapeutics
Explores novel therapeutic combinations including targeted agents for hematologic disorders.
Novel Therapeutic Approaches
Investigates innovative treatment combinations including venetoclax and azacitidine for hematologic conditions, with emphasis on treatment-naïve patients.
- Combination Therapy Development
- First-line Treatment Strategies
- Novel Agent Evaluation
Focuses on developing treatment strategies for previously untreated patients with advanced disease.
Clinical Outcomes
Evaluates therapeutic interventions with particular attention to overall survival in hematologic malignancies.
- Survival Outcome Assessment
- Treatment Response Evaluation
- Safety Profile Analysis
Examines the effectiveness of standard and experimental treatments in high-risk patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.